Form 4/A for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2024-04-26 00:00:00 ET · period of report 2024-04-17 · accession 0001415889-24-011591 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2024-04-26 | 2024-04-17+ | FENC | Haigh Adrian | COO | M - OptEx | $2.31 | +44.4K | 44.4K | New | +$102.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-04-17 | M | A | 22,222 | $2.31 | 22,222 | D | — | — | (F1) On April 18, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of "S" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 17, 2024, and an additional 22,222 common shares on April 18, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023. The correct transaction code for the reporting person's acquisition of these shares is "M". |
| 2 | Common | Common Shares | 2024-04-18 | M | A | 22,222 | $2.31 | 44,444 | D | — | — | (F2) On April 18, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of "S" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 17, 2024, and an additional 22,222 common shares on April 18, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023. The correct transaction code for the reporting person's acquisition of these shares is "M". |